Tahir Amin

speaker

103 appearances 1 recordings 1 series first heard Jul 2026 last heard 6 Jul

Tahir Amin’s voice in public audio — every appearance, attributed to the second.

Trend

recordings per month · last 12 months

Recordings per month over the last 12 months — 1 in all, peaking in Jul 2026 with 1.

Appearances

newest first · ▶ plays the moment

Science Friday · How the US patent system keeps drug prices high · 6 Jul 2026 podcast

Interestingly, with the Ebola issue coming at the moment, there's...

We have a couple of vaccines in the marketplace, but back in 2014, when the first breakout happened, there was basically this monoclonal antibody, I believe, that was sitting on the shelf.

And it only actually got utilized at the very last minute.

And it wasn't utilized in the area, in West Africa, where it was needed.

It was only when, I think it was a Western doctor that contracted Ebola, was flying to the US, and that's when it was used.

And so really, there's a whole...

bunch of uh conditions which don't actually get um sort of investment in because there's no market for these companies to make profits and so that then begs the question what kind of system do we have and unless the companies can get a plethora of patents around it they're not interested so they're only interested in how do i make more money out of this

No, and that is the problem with the measure of our pharmaceutical industry today is not how many lives I can save, it's how much wealth I can make for my shareholders, for dividends that I give back.

That's what the CEOs are measured by in terms of their performance.

Their CEOs, their salaries are measured by that.

That's actually the measure of the pharmaceutical industry today.

That's what they measure themselves by.

So that is a great suggestion.

There are academics who've coined this one and done.

You get one exclusivity.

You have to remember the patent is not the only exclusivity system in the game.

When a drug gets approved, the FDA grants what is called the marketing exclusivity.

So this idea that we need all these exclusivities to give the ROI that these companies need, we've actually over-incentivized them.

And so basically, a one exclusivity system would be great.

But I think we need to go further than that.

Showing 61–80 of 103 · page 4 of 6